Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
09/05 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
01/05 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 4M | |
+9.35% | 4.9B | |
+6.62% | 1.61B | |
+33.26% | 1.24B | |
+82.85% | 881M | |
+26.81% | 850M | |
+25.34% | 636M | |
-28.34% | 534M | |
-.--% | 155M | |
+43.64% | 133M |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.
- JonesTrading Initiates Cullinan Oncology With Buy Rating, Price Target is $22